Vigorous Gainers/Losers Roundup: Valley National Bancorp (NYSE:VLY), Fred’s (NASDAQ:FRED)

Valley National Bancorp (NYSE:VLY) [Trend Analysis] luring active investment momentum, shares surge remains unchanged to $11.68. Valley National Bancorp (VLY) reported that organizational leadership changes in conjunction with the Bank’s long term succession plan. In executing this strategy, we are delighted to announce the promotions of Ira Robbins to President of Valley National Bank and Rudy Schupp as President of Valley National Bancorp and Chief Banking Officer of Valley National Bank.

Chairman and CEO Gerald Lipkin commented that “Mr. Robbins will work closely with the management team and the Board, while overseeing many business units of the bank including the consumer bank, credit division, information technology, bank operations and all financial areas. We are confident of Ira’s capacity to oversee these critical areas of our bank, and direct the execution of Valley’s strategic initiatives. Over the past several years Ira has been a trusted leader and instrumental member of the executive management team. He has added tremendous value to the Bank. The total volume of 228342 shares held in the session was surprisingly higher than its average volume of 2214.67 shares. EPS estimates indicating constrictive facts, the current year from sell-side analysts, Price to current year EPS stands at -25.10%, and looking further price to next year’s EPS is 9.27%. While take a short look on price to sales ratio, that was 4.22 and price to earnings ratio of 25.73 attracting passive investors.

Shares of Fred’s, Inc. (NASDAQ:FRED) [Trend Analysis] runs in leading trade, it plunging -0.11% to trade at $17.92. The firm has price volatility of 2.96% for a week’s and 7.00% for a month. Its beta stands at 1.61 times. Fred’s Inc. (FRED) revealed that its comparable store sales for the month of December declined 3.4% compared with surge of 2.4% in the year-earlier period. Fred’s Pharmacy’s total sales for the month reduced 3.9% to $222.9 million from $232.0 million in December 2015.

Fred’s Pharmacy’s total sales for the year-to-date period reduced 0.8% to $1.978 billion versus $1.994 billion for the same period last year. On a comparable store basis, year-to-date sales declined 2.0% versus surge of 1.5% for the year-earlier period. Narrow down four to firm performance, its weekly performance was -3.96% and monthly performance was 76.92%. The stock price of FRED is moving up from its 20 days moving average with 15.49% and isolated positively from 50 days moving average with 52.54%.

 

About Gerard Bergeron

Gerard Bergeron covers Bio-pharmacy or healthcare sector Press Releases news updates. He has extensive three year of experience in content writing as freelance writer. He performs analysis of Healthcare Companies and provides worthy information for investor community. He is an experienced writer with a precise grasp of the English language and a clear, compelling writing style.

Leave a Reply

Your email address will not be published. Required fields are marked *